Oracle said Saturday that Executive Chair Larry Ellison has canceled a trading plan that could have sold as many as 50 million Oracle shares by Oct. 24. The company said no stock was sold under the plan and that Ellison has no other plan to sell his Oracle stake.
The reversal removes a potential supply overhang worth about $7.51 billion at Oracle’s Friday close. It does not, however, put a dollar into Oracle’s treasury or change the capital bill behind its AI-cloud expansion. That distinction is likely to decide whether any relief rally in ORCL stock at Monday’s open lasts beyond the first reaction.
The plan lasted on investors’ screens for one day
Oracle’s quarterly filing published Friday disclosed that Ellison adopted the Rule 10b5-1 plan on June 22. It was scheduled to end Oct. 24, subject to earlier termination, and permitted sales of up to 50 million shares. Such plans set trading instructions in advance; authorization to sell a maximum amount does not mean all of it would have been sold.
Oracle reported 3,023,736,000 common shares outstanding as of Sept. 7. The canceled maximum therefore represented 1.65% of the company’s share count. It also equaled 63.7% of Friday’s 78.5 million-share trading volume, although any actual plan sales could have been spread across many sessions and constrained by its undisclosed terms.
ORCL closed Friday at $150.28, down 1.7%, according to market data available after the close. Because Oracle announced the cancellation on Saturday, there is no U.S. cash-market price response yet. The first useful read will come in Monday premarket trading and then in the depth of bids after the opening auction—not in weekend commentary.
Why the signal is smaller than the number
The immediate bull case is straightforward: investors no longer have to handicap a large founder sale into a stock already absorbing heavy financing and post-earnings volatility. Ellison also remains economically aligned with shareholders. But Oracle did not explain why he canceled the plan, so treating the decision as a new forecast about revenue, margins or intrinsic value would go beyond the evidence.
More importantly, this was a personal sale plan. Its cancellation does not reverse the $20 billion of common stock Oracle itself issued through an at-the-market program in the August quarter. Nor does it alter the company’s calendar-2026 financing framework, which targeted $45 billion to $50 billion of gross proceeds to build cloud capacity.
The operating case remains unusually large on both sides. Oracle said in its fiscal first-quarter release that remaining performance obligations reached $664 billion after more than $30 billion of new AI-cloud contracts. It also delivered more than 300,000 GPUs to cloud customers during the quarter. Those figures support the demand thesis.
The cash conversion is the counterweight. Oracle’s 10-Q shows $23.10 billion of operating cash flow and $28.50 billion of capital expenditure in the quarter. By subtraction, capex exceeded operating cash flow by about $5.40 billion. Canceling a possible insider sale changes prospective market supply; it does not close that cash gap.
That creates a clean test for Monday. A higher ORCL price would show that investors assigned real weight to the removed overhang. A durable rerating still requires evidence that the $664 billion backlog can convert into revenue and cash quickly enough to justify the financing burden. The strongest counterargument to a large move is also the simplest: none of Ellison’s shares had been sold, so Oracle’s business and balance sheet are exactly where they were on Friday.